# Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

> **NCT00470262** · NA · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 27 (actual)

## Conditions studied

- Metabolic Syndrome X
- Prediabetic State

## Interventions

- **DRUG:** Fenofibrate 145mg PO QD
- **DRUG:** Pioglitazone 45 mg PO QD

## Key facts

- **NCT ID:** NCT00470262
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-12
- **Final completion:** 2014-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470262, "Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00470262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*